Eterna Therapeutics raises up to $7.3M in private placement; resets annual meeting to June 2

Ernexa Therapeutics Inc.

Initial closing on April 2: sold 9.93M shares and 509,736 pre-funded warrants for $1.1M.
Second closing of $6.2M (48.33M shares, 10.54M warrants) subject to stockholder approval by June 30 (or July 30 if SEC reviews).
Purchase price $0.1046 per share; pre-funded warrants at $0.0996 with $0.005 exercise price.
Investors include existing 32% holder Charles Cherington and former director Nicholas Singer.
2025 annual meeting moved to June 2; stockholder proposal deadline is April 13.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001641172-25-002514
form_type: 8-K
ticker: ERNA
cik: 0000748592
company_name: Ernexa Therapeutics Inc.
filed_at: 2025-04-03T23:59:59+00:00
discovered_at: 2026-05-14T18:02:51.149495+00:00
generated_at: 2026-05-23T22:57:59.718753+00:00
sec_items: ["1.01", "3.02", "5.08", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001641172-25-002514
json_url: https://secwatch.observer/filing/0001641172-25-002514.json
markdown_url: https://secwatch.observer/filing/0001641172-25-002514.md
text_url: https://secwatch.observer/filing/0001641172-25-002514.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/748592/000164117225002514/0001641172-25-002514-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/748592/000164117225002514/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

XMax raises $3.6M via private placement of 486,500 shares at $7.347/share

XMax Inc. June 2, 2026, 4:30 PM ET other_material Items 1.01, 3.02, 9.01

same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8

Jaguar Health, Inc. June 2, 2026, 4:10 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

Tempest Therapeutics enters warrant exercise inducement for ~$2M; issues new warrants to purchase 2.34M shares at $1.73

Tempest Therapeutics, Inc. June 1, 2026, 7:13 PM ET other_material Items 1.01, 3.02, 9.01

same SEC item: 1.01, 3.02, 9.01 same event type: other_material similar materiality

OSR Holdings enters $30M asset purchase agreement with subsidiary Vaximm for VXM01 IP

OSR Holdings, Inc. June 2, 2026, 1:16 PM ET other_material Items 1.01, 9.01